| Trial ID: | L6999 |
| Source ID: | NCT02691897
|
| Associated Drug: |
Melatonin
|
| Title: |
Melatonin's Effects on Treatment Of Diabetes Mellitus
|
| Acronym: |
METOD
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus
|
| Interventions: |
DRUG: Melatonin|DRUG: Placebo
|
| Outcome Measures: |
Primary: Fasting blood sugar (FBS), 3 months|HbA1c, 3 months | Secondary: Serum Insulin, 3 months|Weight (Body mass index), 3 months|Waist circumference, 3 months|Serum aminotransferases, 3 months|Number of patients with adverse events, 3 months
|
| Sponsor/Collaborators: |
Sponsor: Shiraz University of Medical Sciences
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
EARLY_PHASE1
|
| Enrollment: |
60
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2019-07
|
| Completion Date: |
2020-07
|
| Results First Posted: |
|
| Last Update Posted: |
2019-04-08
|
| Locations: |
Shahid Motahhari Clinic, Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT02691897
|
